Prokarium secures £4.6m Wellcome funding for Entervax

8th October 2019 Uncategorised 0

The funding will be used for a Phase I study in the UK and a Phase Ib age-descending, dose-escalation study in an endemic region in South Asia.

More: Prokarium secures £4.6m Wellcome funding for Entervax
Source: News